ProKidney to Participate in the Jefferies Global Healthcare Conference

Rhea-AI Summary

ProKidney, a late clinical-stage cellular therapeutics company specializing in chronic kidney disease (CKD), announced its participation in the Jefferies Global Healthcare Conference. The event is scheduled from June 4 to June 6, 2024, in New York, NY.

Senior management will host one-on-one meetings with investors during the conference. To arrange meetings, investors are advised to contact their Jefferies representative.

Positive

• ProKidney's participation in a major healthcare conference can attract new investors.
• Opportunity for one-on-one meetings with senior management may build investor confidence.
• Conference exposure can enhance ProKidney's visibility in the healthcare sector.

Negative

• The press release lacks detailed financial or clinical updates that could impact stock performance.
• No new partnerships, milestones, or clinical results were announced.

WINSTON-SALEM, N.C., May 29, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the Jefferies Global Healthcare Conference taking place from June 4 – 6, 2024 in New York, NY. 

The ProKidney management team will host one-on-one meetings during the event. Interested investors should contact their Jefferies representative to schedule meetings.

About ProKidney
ProKidney, a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT^®), is a first-of-its-kind, patented, proprietary autologous cellular therapy being evaluated to potentially preserve kidney function in diabetic patients at high risk of kidney failure. Rilparencel has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program. For more information, please visit www.prokidney.com.

Investor Contacts:

ProKidney
Ethan Holdaway
Ethan.Holdaway@prokidney.com

LifeSci Advisors, LLC
Daniel Ferry
Daniel@lifesciadvisors.com

FAQ

What event is ProKidney participating in?

ProKidney is participating in the Jefferies Global Healthcare Conference.

When is the Jefferies Global Healthcare Conference happening?

The conference is taking place from June 4 to June 6, 2024.

Where is the Jefferies Global Healthcare Conference held?

The conference is held in New York, NY.

What will ProKidney be doing at the Jefferies Global Healthcare Conference?

Senior members of ProKidney's management team will host one-on-one meetings with investors.

How can investors schedule meetings with ProKidney at the Jefferies Global Healthcare Conference?

Investors should contact their Jefferies representative to schedule meetings.